What You Should Know:
- Philips paves the way for faster lung cancer diagnosis and treatment with advanced 3D imaging and navigation platform with the launch of Azurion Lung Edition.
- By speeding diagnosis and treatment, Azurion Lung Edition
is helping to transform lung cancer care, contributing to dramatically improved
outcomes and reduced costs.
Royal Philips, today
announced the launch of Azurion
Lung Edition, an advanced 3D imaging and navigation platform to accelerate
the
Read More
Lung Cancer
Syapse Lands $30M to Accelerate Real-World Evidence in Oncology
What You Should Know:
- Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine.
- Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine.
Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
Machine Learning Will Transform Medicine, but Only if We Use it Right
World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer.
It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event, the first sign that artificial intelligence could become equal to or even
Read More
Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019
- From Google's acquisition of Fitbit to Philips acquisition of Carestream Health's health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter.
Q1 M&A Activity
Johnson & Johnson Acquires Auris Health for $3.4B to Expand Digital Surgery Portfolio
Johnson & Johnson acquiresAuris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately-held developer of
Read More
McKesson, Aetion Partner on Real-World Evidence (RWE) in Cancer Research
- Aetion and McKesson announced a strategic collaboration focused on advancing the use of real-world evidence (RWE) in cancer research. - Relationship pairs Aetion Evidence Platform and McKesson’s robust oncology data sets to accelerate regulatory-grade oncology studiesAetion and McKesson, today announced a strategic collaboration focused on advancing the use of real-world evidence (RWE) in cancer research to benefit patients, regulators, the biopharma industry, and payers. The partnership will
Read More
AI vs. Humans: AI Solution Beats Stanford Radiologists in Chest X-ray Diagnostics Competition
JF Healthcare, a Nanchang, China-based medical diagnostic startup is the first organization in the world to beat Stanford University radiologists in a competition designed by the Stanford Machine Learning group to compare the capability of artificial intelligence (AI) to human experts in interpreting chest x-rays.Standard Chest X-ray Diagnostic Competition ResultsThe AI team from JF Healthcare recently achieved an average AUC score (a measure of diagnostic accuracy) of 0.926 and is currently
Read More
Belong.Life Raises $14M to Expand AI-Powered Social Network for Cancer Patients
Belong.Life, creators of the "Belong - Beating Cancer Together" mobile app, the world's largest social network and navigator app for cancer patients, caregivers and healthcare professionals announced it has raised $14M in Series B funding led by IQVI. The Series B round also included participation from The Group Ventures and other existing investors.Founded in 2015 by noted entrepreneurs Eliran Malki, Irad Deutsch and Ohad Rubin after each lost relatives to cancer, Belong - Beating Cancer
Read More
Mayo Clinic to Develop New Diagnostic Test Using Patients’ Breath to Detect Lung Cancer
Mayo Clinic Laboratories is teaming up with Breath Diagnostics to develop new clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases. The first collaboration will focus on a diagnostic test that detects lung cancer using patients' exhaled breath. Benefits of BiomarkersBiomarkers are measurable substances that help in predicting the severity of a disease or infection. Examples of a biomarker include an individual's pulse
Read More
AdoRx Therapeutics, J&J Team Up to Develop Novel Lung Cancer Therapeutics
AdoRx Therapeutics, a UK based drug discovery company, and Johnson & Johnson are teaming up to develop novel therapeutics for the treatment of lung cancer. As part of the strategic collaboration, AdoRx has granted an exclusive option to research, develop and commercialize novel antagonists within the AdoRx portfolio, and the groups will collaborate on drug discovery and preclinical development activities. AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer-based on
Read More
Montefiore Health to Create AI-Based Screening Tool to Help Doctors Identify Lung Failure
Funded by a $1.2 million Agency for Healthcare Research and Quality grant, Montefiore Health System is building a new artificial intelligence (AI) screening tool to help doctors better identify and treat acute respiratory distress syndrome (ARDS), a deadly, but under-recognized, form of lung failure. Acute respiratory distress syndrome (ARDS) is a rapidly progressive disease occurring in critically ill patients.The main complication in ARDS is that fluid leaks into the lungs making breathing
Read More
